CytoCore to merge with another maker of cancer diagnostic equipment

SHARE CytoCore to merge with another maker of cancer diagnostic equipment

CytoCore has agreed to acquire Orlando-based Medite Group, another maker of cancer diagnostic equipment, in an all stock deal.

“The new demands being placed on labs resulting from the passage of the Affordable Care Act, and the 1.6 million new cancer cases (2012) in the U.S., the combined company will leverage its expertise to continue developing new cancer diagnostic tools to improve early detection of these cancers,” the companies said in a joint statement.

Medite shareholders will control 80 percent of the combined company, which will be based in Orlando. The purpose of the reverse merger is Medite will gain CytoCore’s U.S. stock listing, spokeswoman Janine McCargo told the Orlando Business Journal.

h/t Chicago Business Journal

The Latest
The movie is returning to theaters and there’s a new 4K Ultra HD package you can possess — unless it possesses you first.
The Slamming Salmon Nightmares Tournament gave a chance to fish (catch some), eat and share memories Saturday at Jackson Park.
A woman was struck by a white SUV about 10:45 p.m. in the 5900 block of South King Drive.
From Elon Musk to Donald Trump to Tucker Carlson, egomaniacs are deforming our society — and their narcissism is no longer considered a fault.
Sip & Savor coffee shop and Southern Chicago restaurant are moving into an area that’s seen major chains move or pull back from the busy Roosevelt Road corridor.